With a market cap of has a large market cap size. Sanofi (NYSE: SNY) has been on the stock market since its IPO date on the 7/1/2002. Sanofi is in the Drug Manufacturers – Major industry and Healthcare sector. Average volume for Sanofi, is 2213.62, and so far today it has a volume of 387933. Performance year to date since the 7/1/2002 is -2.85%.
To help you determine whether Sanofi is undervalued the following values will help you decide. P/E is 22.48 and forward P/E is 13.06. PEG perhaps more useful shows that Sanofi has a value for PEG of 3.51. P/S ratio is 2.7 and the P/B ratio is 1.7. The P/Cash and P/Free cash flow is 14.85 and *TBA respectively.
At the current price Sanofi is trading at, 39.52 (-0.61% today), Sanofi has a dividend yield of 4.18%, and this is covered by a payout ratio of *TBA. Earnings per share (EPS) is 1.77, and this is looking to grow in the next year to -1.62% after growing 4.10% this past year. EPS growth quarter over quarter is -56.00%, and -54.00% for sales growth quarter over quarter.
The number of shares outstanding is 2581.58, and the number of shares float is 2304.07. The senior management bring insider ownership to 16.40%, and institutional ownership is at 10.10%. The float short is 0.15%, with the short ratio at a value of 1.51. Management has seen a return on assets of *TBA, and also a return on investment of 6.50%.
The ability for Sanofi, to deal with debt, means it current ratio is 1.5, and quick ratio is 1. Long term debt/equity is 0.27 and total debt/equity is 0.32. In terms of margins, Sanofi has a gross margin of 68.90%, with its operating margin at *TBA, and Sanofi has a profit margin of *TBA.
The 52 week high is -21.36%, with 9.43% being its 52 week low. The 20 day simple moving average is -2.98% and the 200 day simple moving average is -2.05%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.